Crossroads Treatment Center of Greensboro, P.C., reached a civil settlement agreement with the North Carolina Attorney General's Office regarding the agency's review of certain codes used in a ...
An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.
Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today ...
North Carolina Attorney General Jeff Jackson on Wednesday announced a $584,143 settlement with a Greensboro-based subtance ...
For a third consecutive year, fatal drug overdose deaths declined in the U.S. Unfortunately, not every state has followed ...
Drug overdoses have declined for a third straight year, according to preliminary data released by the CDC on May 13. 1 The ...
Study now open for enrollment at leading academic medical centersCARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results